Chemotherapy Induced Peripheral Neuropathy Market Gains Momentum...

blog ekledi Teknoloji

2026-06-04 12:58:09

Chemotherapy Induced Peripheral Neuropathy Market Gains Momentum Across the United States

Chemotherapy-Induced Peripheral Neuropathy (CIPN) is one of the most common and challenging side effects associated with cancer therapy, affecting patients' quality of life and treatment outcomes. According to market estimates, the chemotherapy induced peripheral neuropathy market is expected to grow from US$ 1.01 billion in 2025 to US$ 1.67 billion by 2034, registering a CAGR of 5.71% during...

0 Yorumlar 0 Paylaşımlar 42 Görüntülenme 0 İncelemeler